Heilongjiang ZBD Pharmaceutical Co., Ltd. (SHA:603567)

Market Cap	11.70B
Revenue (ttm)	2.06B
Net Income (ttm)	220.15M
Shares Out	939.40M
EPS (ttm)	0.23
PE Ratio	53.23
Forward PE	n/a
Dividend	0.15 (1.20%)
Ex-Dividend Date	n/a

Volume	45,230,132
Average Volume	11,348,326
Open	12.39
Previous Close	11.99
Day's Range	12.35 - 12.89
52-Week Range	9.81 - 13.63
Beta	0.25
RSI	67.66
Earnings Date	Aug 30, 2025

About SHA:603567

Heilongjiang ZBD Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of Chinese medicines in China. It offers cardiovascular and cerebrovascular, respiratory system, orthopedics, tumors, digestive system, anti-infection, mental nerve, genitourinary, and other disease fields. The company was founded in 1996 and is based in Hulin, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1996
• Employees: 2,349
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 603567

Financial Performance

In 2024, SHA:603567's revenue was 2.70 billion, a decrease of -13.84% compared to the previous year's 3.14 billion. Earnings were 438.22 million, a decrease of -7.30%.